TSE:SVA

Sernova (SVA) Stock Price, News & Analysis

C$0.44
+0.01 (+2.30%)
(As of 04/23/2024 ET)
Today's Range
C$0.44
C$0.45
50-Day Range
C$0.40
C$0.70
52-Week Range
C$0.38
C$1.15
Volume
53,635 shs
Average Volume
151,162 shs
Market Capitalization
C$135.02 million
P/E Ratio
N/A
Dividend Yield
7.86%
Price Target
C$1.50

Sernova MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
237.1% Upside
C$1.50 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.70 out of 5 stars

SVA stock logo

About Sernova Stock (TSE:SVA)

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.

SVA Stock Price History

SVA Stock News Headlines

Exposed: 10 CENT Crypto to Explode April 20th?
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
Sernova Corp (PSH.MU)
Sernova Corp SVA
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
H.C. Wainwright Thinks Sernova’s Stock is Going to Recover
H.C. Wainwright Reaffirms Their Buy Rating on Sernova (SVA)
Sernova (SVA) Gets a Buy Rating from Echelon Wealth Partners
Echelon Wealth Partners Maintains Their Buy Rating on Sernova (SVA)
Closing Bell: Sernova Corp flat on Wednesday (SVA)
Closing Bell: Sernova Corp up on Friday (SVA)
Closing Bell: Sernova Corp flat on Friday (SVA)
Closing Bell: Sernova Corp down on Tuesday (SVA)
Closing Bell: Sernova Corp up on Monday (SVA)
Closing Bell: Sernova Corp down on Friday (SVA)
See More Headlines
Receive SVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sernova and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/18/2024
Today
4/23/2024
Next Earnings (Estimated)
6/11/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
1,959
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$1.50
High Stock Price Target
C$1.50
Low Stock Price Target
C$1.50
Potential Upside/Downside
+237.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
C$-40,730,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.07 per share
Book Value
C$0.01 per share

Miscellaneous

Free Float
N/A
Market Cap
C$135.02 million
Optionable
Not Optionable
Beta
1.60
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Philip M. Toleikis B.A.
    M.Sc., Ph.D., President, CTO, Director of Technology & Director
  • Mr. Christopher Barnes
    Vice President of Investor Relations
  • Dr. Frank Shannon M.D.
    Vice President of Clinical Development & Regulatory Affairs
  • Ms. Cynthia Pussinen
    CEO & Director
  • Mr. Nicholas J. Rossettos CPA (Age 58)
    M.B.A., Interim Chief Financial Officer
  • Mr. Douglas Maret
    Chief Science Officer
  • Dr. Modestus Obochi M.B.A.
    Ph.D., Chief Business Officer

SVA Stock Analysis - Frequently Asked Questions

Should I buy or sell Sernova stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sernova in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" SVA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SVA, but not buy additional shares or sell existing shares.
View SVA analyst ratings
or view top-rated stocks.

What is Sernova's stock price target for 2024?

1 equities research analysts have issued 12 month target prices for Sernova's stock. Their SVA share price targets range from C$1.50 to C$1.50. On average, they anticipate the company's share price to reach C$1.50 in the next twelve months. This suggests a possible upside of 237.1% from the stock's current price.
View analysts price targets for SVA
or view top-rated stocks among Wall Street analysts.

How have SVA shares performed in 2024?

Sernova's stock was trading at C$0.70 on January 1st, 2024. Since then, SVA stock has decreased by 36.4% and is now trading at C$0.45.
View the best growth stocks for 2024 here
.

When is Sernova's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 11th 2024.
View our SVA earnings forecast
.

How were Sernova's earnings last quarter?

Sernova Corp. (TSE:SVA) posted its quarterly earnings results on Monday, March, 18th. The company reported ($0.03) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.03).

How do I buy shares of Sernova?

Shares of SVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:SVA) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners